Intelliprove

Measuring vital parameters without wearable devices has long been a frontier of digital health. Intelliprove has developed a facial scanning technology that, through analysis of subtle optical signals detectable on the face via a smartphone or computer camera, is capable of extracting clinically relevant biomarkers: heart rate, heart rate variability, respiratory rate, and other parameters related to stress and wellbeing. The technology leverages remote photoplethysmography: minute variations in skin colour, invisible to the human eye but detectable by a digital camera, reflect blood flow and allow inference of cardiovascular parameters with clinically validated precision. No device needs to be touched, no sensor worn, no complex procedures followed: simply positioning in front of a camera for a few seconds is sufficient. The company's positioning is that of a B2B technology provider: Intelliprove does not develop direct consumer applications but offers its technology as an embeddable component in healthtech platforms, corporate wellbeing apps, insurance products, and remote patient monitoring solutions. Clinical validation is the pillar on which the credibility of the proposition rests: in a sector where technological claims are abundant but concrete evidence is scarce, having clinical data supporting measurement accuracy is an essential differentiator. The digital health market is vast and growing rapidly, with companies across sectors looking for ways to monitor employee wellbeing, reduce insurance costs, and offer preventive health services. Intelliprove enters this flow as an enabling technology infrastructure, with a model that can scale rapidly through integrations with client platforms, multiplying the reach of the technology without having to build a direct relationship with every end user.